查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433624

兽用肾病变市场规模、份额、趋势分析报告：按类型、动物类型、途径、适应症、分销管道、地区和细分市场预测，2024-2030 年

Veterinary Renal Disease Market Size, Share & Trends Analysis Report By Type, By Animal Type (Canine, Feline, Bovine, Equine, Others), By Route of Administration, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 154 Pages | 商品交期: 2-10个工作天内

价格

兽医肾病变市场成长与趋势：

根据Grand View Research, Inc.最新报告显示，到2030年，全球兽用肾病变市场规模预计将达229亿美元，预计2024年至2030年复合年增长率为5.49%。

肾臟疾病盛行率的上升和采用治疗性饮食作为治疗方法是该市场的主要成长动力。慢性肾臟病（CKD）、肾衰竭等肾臟疾病会对动物的肾臟系统造成不可逆的损害。儘管这种疾病没有明确的治疗方法，但透过不同类型的治疗方法进行适当的管理可以改善动物的生活。最重要的方法之一是透过治疗性饮食进行营养管理。

另一个关键的市场驱动因素是人工智慧在兽医肾臟疾病诊断和治疗中的日益采用。诊断影像在兽医学中发挥着重要作用，它不仅为疾病和损伤的评估提供重要资料，而且还为常规预防措施提供重要数据。事实证明，人工智慧是一种极其有价值的工具，尤其是在放射科医生短缺的地区。更快和增强的诊断能力等相关优势预计将增加人工智慧的采用，从而在不久的将来对市场产生积极影响。

动物医学领域的知名公司玛氏早已进入将人工智慧应用于兽医诊疗领域。 2019年，Antech Diagnostics（火星）推出了尖端诊断工具RenalTech。 RenalTech 使用人工智慧 (AI) 评估宠物医疗记录资料，以预测猫患慢性肾臟病(CKD) 的风险，最多可比临床诊断提前两年。

此外，产品系列扩张、併购和整合活动等市场动态预计将为该市场提供成长基础。例如，2023 年 9 月，Elanco Animal Health 的 Varenzin-CA1（莫利司他口服混悬液）获得美国FDA 有条件核准，用于治疗患有慢性肾臟病（CKD）的猫的非再生性贫血。此外，2023 年 12 月，Neogen 公司与佛罗里达州米亚卡市的 TerraNova 马术中心合作，成为该设施诊断测试产品的官方生物安全提供者。

兽医肾臟病市场报告亮点

  • 按类型划分，治疗细分市场将在 2023 年以 68.99% 的最大收益占有率引领市场。这是由于可用的治疗方法丰富以及全球宠物数量不断增长。
  • 按动物类型划分，猫科动物预计在预测期内将以最快的复合年增长率增长。
  • 根据给药途径，口服细分市场将在 2023 年占据最大的收益占有率，而注射细分市场预计在预测期内复合年增长率最快。
  • 根据迹象，肾炎细分市场预计将在 2023 年占据最大的收益占有率，达到 29.74%，预计肾炎细分市场在预测期内的复合年增长率第二快。
  • 动物各种肾臟併发症率的上升、宠物食品的大量使用以及疾病意识倡议的提高都促进了市场的成长。
  • 2023 年，北美市场占据最大的收益占有率。全部区域整体兽医保健的重要性日益增加，被认为是推动市场扩张的关键因素。美国宠物产品协会估计，2023年至2024年，美国将有6,510万个家庭拥有宠物。此外，饲主对动物健康以及为肾功能不全动物提供护理重要性的认识不断提高，也推动了北美市场的扩张。
  • 2023 年 5 月，Dechra Pharmaceuticals 宣布了两种支持老年猫肾臟健康的产品的商业权：Porus One 和 Add One。 Porus One 含有 Renaltec，这是一种选择性吸收剂，可以吸收猫肠道中尿毒症毒素的前体，这些毒素通常会被健康的肾臟清除或调节。 Add One 是一种专为老年猫开发的湿猫零食，鼓励它们吃 Poluswan，据说对喜欢干粮的猫很有用。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章兽用肾病市场：变数、趋势和范围

  • 市场体系展望
  • 法律规范
  • 按主要物种和主要国家分類的宠物数量估计（2018-2023）
  • 2022 年及 2023 年美国宠物主人人口统计（世代）
  • 宠物肾臟疾病的盛行率
  • 产品价格分析
  • 消费者偏好分析
  • 兽用肾病变市场动态
  • 兽医肾臟病市场：波特五力分析
  • 兽医肾臟病市场：PESTEL 分析
  • COVID-19 影响分析

第四章 2018-2030 年类型估计与趋势分析（百万美元）

  • 按类型分類的兽医肾臟病市场：要点
  • 2023年和2030年类型变化分析和市场占有率
  • 按类型
  • 诊断
  • 治疗

第五章 2018-2030年动物类型估算与趋势分析（百万美元）

  • 按动物类型分類的兽用肾病市场：要点
  • 2023年和2030年动物类型变化分析和市场占有率
  • 依动物类型
  • 狗
  • 猫
  • 牛
  • 马
  • 其他的

第六章 2018-2030 年给药途径估算与趋势分析（百万美元）

  • 按给药途径分類的兽用肾病变市场：要点
  • 2023年及2030年行政途径变化分析及市场占有率
  • 依给药途径
  • 口服
  • 注射

第七章 2018-2030年指标估算与趋势分析（百万美元）

  • 按适应症分類的兽用肾病市场：重点
  • 2023年和2030年的指示变化分析和市场占有率
  • 按指示
  • 肾衰竭
  • 慢性肾臟病（CKD）
  • 肾性膀胱炎
  • 肾结石
  • 肾炎
  • 其他的

第8章 2018-2030年通路估算与趋势分析（百万美元）

  • 按分销管道分類的兽用肾病市场：要点
  • 2023年及2030年通路波动分析及市场占有率
  • 按分销管道
  • 动物医院/诊所
  • 宠物专卖店
  • 电子商务
  • 其他的

第 9 章 2018-2030 年区域估计与趋势分析（百万美元）

  • 区域展望
  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场、要点
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 丹麦
    • 挪威
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 科威特
    • 阿拉伯聯合大公国

第10章竞争形势

  • 参与企业概况
  • 财务绩效
  • 服务标竿
  • 市场参与企业分类
  • 2022年预计市场情势分析（热图分析）
  • 策略规划
    • 扩张
    • 併购
    • 伙伴关係与协作
    • 启动/扩展服务
    • 其他的
  • 公司简介
    • Mars inc.
    • Nestle Purina Petcare
    • Hills Pet Nutrition.
    • JM Smucker.
    • General Mills
    • Zoetis Inc.
    • Merck &Co. Inc.
    • Elanco.
    • Phibro Animal Health Corporation.
    • Ceva Sante Animale
    • Boehringer Ingelheim Animal Health
    • Dechra Pharmceuticals
    • VetPharma
    • Vedco Inc.
    • Mission Pharmacal Company
    • Rayne Clinical Nutrition
    • Neogen Corporation.
    • Roquette Freres
    • JP Farma
    • Richmond Vet Pharma
    • IDEXX Laboratories Inc.
    • Fujifilm Holdings Corporation
    • Carestream Health.
    • Mindray Bio-Medical Electronics Co., Ltd.

第11章 要点

Product Code: GVR-4-68040-187-4

Veterinary Renal Disease Market Growth & Trends:

The global veterinary renal disease market size is anticipated to reach USD 22.90 billion by 2030 and it is projected to grow at a CAGR of 5.49% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of renal diseases coupled with adoption of therapeutic food as a treatment are key growth drivers for this market. Renal diseases like chronic kidney disease (CKD), renal failure, etc. cause irreversible damage to the renal system of animals. Despite no definite cure for this disease, proper management by various types of therapies can help in the betterment of animal life. One of the most prominent methods is that of nutritional management through therapeutic food.

Another crucial market propeller is the rising adoption of AI in veterinary renal disease diagnostics and treatment. Imaging plays a significant role in veterinary medicine by offering vital data for regular preventative measures as well as the assessment of disease and injury. AI can prove to be a very beneficial tool, especially in radiologist deficient geographies. Associated benefits such as faster and enhanced diagnostic capabilities is anticipated to increase adoption of AI and thereby influence positively on market in near future.

Mars Inc, which is a prominent player in the animal health space, has already stepped into the field of applying AI to veterinary diagnostics and treatment. Antech Diagnostics (Mars Inc.) introduced RenalTech, a cutting-edge diagnostic tool, in 2019. RenalTech uses artificial intelligence (AI) to evaluate pet medical record data and forecast a cat's risk of developing chronic kidney disease (CKD) up to two years ahead of an established clinical diagnosis.

Moreover, market dynamics such as product portfolio expansion, M&A, consolidation activities are further anticipated to provide growth platform to this market. For example, in September 2023, Elanco Animal Health received conditional U.S. FDA approval for Varenzin-CA1 (molidustat oral suspension), as the treatment to control non-regenerative anemia in cats with chronic kidney disease (CKD). Furthermore , in December 2023, Neogen Corporation partnered with the TerraNova Equestrian Center in Myakka City, Florida, making the company the official biosecurity provider of the facility for diagnostic testing products.

Veterinary Renal Disease Market Report Highlights:

  • Based on type, the treatment segment led the market with the largest revenue share of 68.99% in 2023, due to the wide array of treatments available coupled with ever growing population of pets globally
  • Based on animal type, the feline segment is expected to grow at the fastest CAGR over the forecast period
  • Based on route of administration, the oral segment held the largest revenue share in 2023 and the injectable segment is expected to have the fastest CAGR over the forecast period
  • Based on the indication, the renal cystitis segment held the largest revenue share of 29.74% in 2023 and nephritis segment is expected to have the second fastest CAGR over the forecast period
  • Rising prevalence of a variety of renal complications in animals, prominent usage of pet food, growing disease awareness initiatives are contributing to the market growth
  • North America accounted for the largest revenue share of the market in 2023. The increasing significance of animal health care in general throughout the region has been identified as a key factor propelling market expansion. The American Pet Products Association estimates that 65.1 million homes in the country have pets in 2023-2024. Moreover, growing pet owners' awareness of animal health and the significance of providing care for animals with renal disorders are fueling the market expansion in North America
  • In May 2023, Dechra Pharmaceuticals announced distribution rights of two products to support kidney health in senior cats - Porus One, and Add One. Porus One contains renaltec, a selective absorber that soaks up precursors of uremia toxins in the cat's intestines that would ordinarily be removed or regulated by healthy kidneys. Add One is a moist cat treat designed for senior cats, developed to encourage them to eat Porus One, and is said to be useful for cats that prefer dry food

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Regional Scope
    • 1.1.2 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information/Data Analysis
    • 1.4.1 Information Analysis
  • 1.5 Market Formulation & Visualization
  • 1.6 Data Validation & Publishing
  • 1.7 Model Details
    • 1.7.1 Approach 1: Commodity Flow Analysis
      • 1.7.1.1 Hybrid Market Estimation Model
    • 1.7.2 Approach 2: Volume-Price Analysis (Bottom-Up)
    • 1.7.3 Approach 3: Ancillary Market Analysis
    • 1.7.4 Global Market: Cagr Calculation
  • 1.8 List Of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Veterinary Renal Diseases Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Regulatory Framework
    • 3.2.1 North America
    • 3.2.2 Europe
    • 3.2.3 Asia Pacific
    • 3.2.4 Latin America
    • 3.2.5 Mea
  • 3.3 Estimated Pet Population By Key Species & Key Countries (2018-2023)
  • 3.4 U.S. Pet Owner Demographics, 2022 & 2023, By Generation
  • 3.5 Prevalence Of Pet Renal Diseases
  • 3.6 Product Price Analysis
  • 3.7 Consumer Preference Analysis
  • 3.8 Veterinary Renal Diseases Market Dynamics
    • 3.8.1 Market Driver Impact Analysis
      • 3.8.1.1 Rising Prevalence Of A Variety Of Renal Complications In Animals
      • 3.8.1.2 Prominent Usage Of Pet Food
      • 3.8.1.3 Growing Disease Awareness Initiatives
    • 3.8.2 Market Restraint Analysis
      • 3.8.2.1 Off-Label Use Of Drugs In Veterinary Treatment
      • 3.8.2.2 Lack Of Structured Regulations And Quality Control
  • 3.9 Veterinary Renal Diseases Market: Porter's 5 Forces Analysis
    • 3.9.1 Threat Of New Entrants: Moderate
    • 3.9.2 Threat Of Substitutes: Low To Moderate
    • 3.9.3 Bargaining Power Of Buyers: Moderate To High
    • 3.9.4 Bargaining Power Of Suppliers: Low
    • 3.9.5 Competitive Rivalry: High
  • 3.10 Veterinary Renal Diseases Market: Pestel Analysis
    • 3.10.1 Political & Legal
    • 3.10.2 Economic
    • 3.10.3 Social
    • 3.10.4 Technological
    • 3.10.5 Environmental
  • 3.11 Covid-19 Impact Analysis
    • 3.11.1 Pre & Current Impact And Future Scenario
    • 3.11.2 Impact Of Covid-19 On Market Players

Chapter 4 Type Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 4.1 Veterinary Renal Diseases Market By Type: Key Takeaways
  • 4.2 Type Movement Analysis & Market Share, 2023 & 2030
  • 4.3 Veterinary Renal Diseases Market Estimates & Forecast, By Type (USD Million)
  • 4.4 Diagnosis
    • 4.4.1 Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.1 Test Kits & Consumables
      • 4.4.1.1.1 Test Kits & Consumables Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.2 Instruments
      • 4.4.1.2.1 Instruments Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.5 Treatment
    • 4.5.1 Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1 Drugs
      • 4.5.1.1.1 Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1.1.2 Nsaids
      • 4.5.1.1.1.2.1 Nsaids Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1.1.3 Antibiotics
      • 4.5.1.1.1.3.1 Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1.1.4 Cystine-Binding Agents
      • 4.5.1.1.1.4.1 Cystine Binding Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1.1.5 Diuretics
      • 4.5.1.1.1.5.1 Diuretics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1.1.6.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.2 Therapeutic Food Supplements
      • 4.5.1.2.1 Therapeutic Food Supplements Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.3 Ringer Lactate Solution
      • 4.5.1.3.1 Ringer Lacate Solution Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Animal Type Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 5.1 Veterinary Renal Diseases Market By Animal Type: Key Takeaways
  • 5.2 Animal Type Movement Analysis & Market Share, 2023 & 2030
  • 5.3 Veterinary Renal Diseases Market Estimates & Forecast, By Animal Type (USD Million)
  • 5.4 Canine
    • 5.4.1 Canine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5 Feline
    • 5.5.1 Feline Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6 Bovine
    • 5.6.1 Bovine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.7 Equine
    • 5.7.1 Equine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.8 Others
    • 5.8.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Route Of Administration Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 6.1 Veterinary Renal Diseases Market By Indication: Key Takeaways
  • 6.2. Route Of Administration Movement Analysis & Market Share, 2023 & 2030
  • 6.3 Veterinary Renal Diseases Market Estimates & Forecast, By Route Of Administration (USD Million)
  • 6.4 Oral
    • 6.4.1 Oral Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5 Injectable
    • 6.5.1 Injectable Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Indication Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 7.1 Veterinary Renal Diseases Market By Indication: Key Takeaways
  • 7.2. Indication Movement Analysis & Market Share, 2023 & 2030
  • 7.3. Veterinary Renal Diseases Market Estimates & Forecast, By Indication (USD Million)
  • 7.4. Renal Failure
    • 7.4.1 Renal Failure Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5 Chronic Kidney Diseases (Ckd)
    • 7.5.1 Chronic Kidney Diseases (Ckd) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6 Renal Cystitis
    • 7.6.1 Renal Cystitis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7 Kidney Stones
    • 7.7.1 Kidney Stones Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8 Nephritis
    • 7.8.1 Nephritis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.9 Others
    • 7.9.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Distribution Channel Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 8.1 Veterinary Renal Diseases Market By Distribution Channel: Key Takeaways
  • 8.2 Distribution Channel Movement Analysis & Market Share, 2023 & 2030
  • 8.3 Veterinary Renal Diseases Market Estimates & Forecast, By Distribution Channel (USD Million)
  • 8.4 Veterinary Hospitals & Clinics
    • 8.4.1 Veterinary Hospitals & Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5 Pet Specialty Stores
    • 8.5.1 Pet Specialty Stores Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6 E-Commerce
    • 8.6.1 E-Commerce Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7 Others
    • 8.7.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9 Regional Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 9.1 Regional Outlook
  • 9.2 Regional Market Share Analysis, 2023 & 2030
  • 9.3 Regional Marketplace, Key Takeaways
  • 9.4 Regional Marketplace, Key Takeaways
  • 9.5 North America
    • 9.5.1 Swot Analysis:
    • 9.5.2 North America Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3 U.S.
      • 9.5.3.1 Key Country Dynamics
      • 9.5.3.2 U.S. Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4 Canada
      • 9.5.4.1 Key Country Dynamics
      • 9.5.4.2 Canada Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6 Europe
    • 9.6.1 Swot Analysis:
    • 9.6.2 Europe Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3 Germany
      • 9.6.3.1 Key Country Dynamics
      • 9.6.3.2 Germany Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4 Uk
      • 9.6.4.1 Key Country Dynamics
      • 9.6.4.2 Uk Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5 France
      • 9.6.5.1 Key Country Dynamics
      • 9.6.5.2 France Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.6 Spain
      • 9.6.6.1 Key Country Dynamics
      • 9.6.6.2 Spain Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.7 Italy
      • 9.6.7.1 Key Country Dynamics
      • 9.6.7.2 Italy Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.8 Denmark
      • 9.6.8.1 Key Country Dynamics
      • 9.6.8.2 Denmark Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.9 Norway
      • 9.6.9.1 Key Country Dynamics
      • 9.6.9.2 Norway Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.9 Sweden
      • 9.6.9.1 Key Country Dynamics
      • 9.6.9.2 Sweden Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7 Asia Pacific
    • 9.7.1 Swot Analysis
    • 9.7.2 Asia Pacific Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.3 Japan
      • 9.7.3.1 Key Country Dynamics
      • 9.7.3.2 Japan Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.4 China
      • 9.7.4.1 Key Country Dynamics
      • 9.7.4.2 China Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.5 India
      • 9.7.5.1 Key Country Dynamics
      • 9.7.5.2 India Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.6 Australia
      • 9.7.6.1 Key Country Dynamics
      • 9.7.6.2 Australia Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.7 South Korea
      • 9.7.7.1 Key Country Dynamics
      • 9.7.7.2 South Korea Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.8 Thailand
      • 9.7.8.1 Key Country Dynamics
      • 9.7.8.2 Thailand Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8 Latin America
    • 9.8.1 Latin America Swot Analysis
    • 9.8.2 Latin America Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.3 Brazil
      • 9.8.3.1 Key Country Dynamics
      • 9.8.3.2 Brazil Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.4 Mexico
      • 9.8.4.1 Mexico Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.5 Argentina
      • 9.8.5.1 Argentina Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.9 MEA
    • 9.9.1 MEA SWOT ANALYSIS
    • 9.9.2 MEA Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.9.3 South Africa
      • 9.9.3.1 Key Country Dynamics
      • 9.9.3.2 South Africa Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.9.4 Saudi Arabia
      • 9.9.4.1 Saudi Arabia Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.9.5 Kuwait
      • 9.9.5.1 Kuwait Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.9.6 UAE

Chapter 10 Competitive Landscape

  • 10.1 Participants' Overview
  • 10.2 Financial Performance
  • 10.3 Service Benchmarking
  • 10.4 Market Participant Categorization
  • 10.5 Estimated Market Position Analysis, 2022 (Heat Map Analysis)
  • 10.6 Strategy Mapping
    • 10.6.1 EXPANSION
    • 10.6.2 MERGERS & ACQUISITIONS
    • 10.6.3 PARTNERSHIPS & COLLABORATIONS
    • 10.6.4 SERVICE LAUNCHES/ EXPANSIONS
    • 10.6.5 OTHERS
  • 10.7 Company Profiles
    • 10.7.1. Mars inc.
      • 10.7.1.1. Participant's overview
      • 10.7.1.2. Financial performance
      • 10.7.1.3. Product benchmarking
      • 10.7.1.4. Strategic initiatives
    • 10.7.2. Nestle Purina Petcare
      • 10.7.2.1. Participant's overview
      • 10.7.2.2. Financial performance
      • 10.7.2.3. Product benchmarking
      • 10.7.2.4. Strategic initiatives
    • 10.7.3. Hills Pet Nutrition.
      • 10.7.3.1. Participant's overview
      • 10.7.3.2. Financial performance
      • 10.7.3.3. Product benchmarking
      • 10.7.3.4. Strategic initiatives
    • 10.7.4. J M Smucker.
      • 10.7.4.1. Participant's overview
      • 10.7.4.2. Financial performance
      • 10.7.4.3. Product benchmarking
      • 10.7.4.4. Strategic initiatives
    • 10.7.5. General Mills
      • 10.7.5.1. Participant's overview
      • 10.7.5.2. Financial performance
      • 10.7.5.3. Product benchmarking
      • 10.7.5.4. Strategic initiatives
    • 10.7.6. Zoetis Inc.
      • 10.7.6.1. Participant's overview
      • 10.7.6.2. Financial performance
      • 10.7.6.3. Product benchmarking
      • 10.7.6.4. Strategic initiatives
    • 10.7.7. Merck & Co. Inc.
      • 10.7.7.1. Participant's overview
      • 10.7.7.2. Financial performance
      • 10.7.7.3. Product benchmarking
      • 10.7.7.4. Strategic initiatives
    • 10.7.8. Elanco.
      • 10.7.8.1. Participant's overview
      • 10.7.8.2. Financial performance
      • 10.7.8.3. Product benchmarking
      • 10.7.8.4. Strategic initiatives
    • 10.7.9. Phibro Animal Health Corporation.
      • 10.7.9.1. Participant's overview
      • 10.7.9.2. Financial performance
      • 10.7.9.3. Product benchmarking
      • 10.7.9.4. Strategic initiatives
    • 10.7.10. Ceva Sante Animale
      • 10.7.10.1. Participant's overview
      • 10.7.10.2. Financial performance
      • 10.7.10.3. Product benchmarking
      • 10.7.10.4. Strategic initiatives
    • 10.7.11. Boehringer Ingelheim Animal Health
      • 10.7.11.1. Participant's overview
      • 10.7.11.2. Financial performance
      • 10.7.11.3. Product benchmarking
      • 10.7.11.4. Strategic initiatives
    • 10.7.12. Dechra Pharmceuticals
      • 10.7.12.1. Participant's overview
      • 10.7.12.2. Financial performance
      • 10.7.12.3. Product benchmarking
      • 10.7.12.4. Strategic initiatives
    • 10.7.13. VetPharma
      • 10.7.13.1. Participant's overview
      • 10.7.13.2. Financial performance
      • 10.7.13.3. Product benchmarking
      • 10.7.13.4. Strategic initiatives
    • 10.7.14. Vedco Inc.
      • 10.7.14.1. Participant's overview
      • 10.7.14.2. Financial performance
      • 10.7.14.3. Product benchmarking
      • 10.7.14.4. Strategic initiatives
    • 10.7.15. Mission Pharmacal Company
      • 10.7.15.1. Participant's overview
      • 10.7.15.2. Financial performance
      • 10.7.15.3. Product benchmarking
      • 10.7.15.4. Strategic initiatives
    • 10.7.16. Rayne Clinical Nutrition
      • 10.7.16.1. Participant's overview
      • 10.7.16.2. Financial performance
      • 10.7.16.3. Product benchmarking
      • 10.7.16.4. Strategic initiatives
    • 10.7.17. Neogen Corporation.
      • 10.7.17.1. Participant's overview
      • 10.7.1.2. Financial performance
      • 10.7.17.3. Product benchmarking
      • 10.7.17.4. Strategic initiatives
    • 10.7.18. Roquette Freres
      • 10.7.18.1. Participant's overview
      • 10.7.18.2. Financial performance
      • 10.7.18.3. Product benchmarking
      • 10.7.18.4. Strategic initiatives
    • 10.7.19. JP Farma
      • 10.7.19.1. Participant's overview
      • 10.7.19.2. Financial performance
      • 10.7.19.3. Product benchmarking
      • 10.7.19.4. Strategic initiatives
    • 10.7.20. Richmond Vet Pharma
      • 10.7.20.1. Participant's overview
      • 10.7.20.2. Financial performance
      • 10.7.20.3. Product benchmarking
      • 10.7.20.4. Strategic initiatives
    • 10.7.21. IDEXX Laboratories Inc.
      • 10.7.21.1. Participant's overview
      • 10.7.21.2. Financial performance
      • 10.7.21.3. Product benchmarking
      • 10.7.21.4. Strategic initiatives
    • 10.7.22. Fujifilm Holdings Corporation
      • 10.7.22.1. Participant's overview
      • 10.7.22.2. Financial performance
      • 10.7.22.3. Product benchmarking
      • 10.7.22.4. Strategic initiatives
    • 10.7.23. Carestream Health.
      • 10.7.23.1. Participant's overview
      • 10.7.23.2. Financial performance
      • 10.7.23.3. Product benchmarking
      • 10.7.23.4. Strategic initiatives
    • 10.7.24. Mindray Bio-Medical Electronics Co., Ltd.
      • 10.7.24.1. Participant's overview
      • 10.7.24.2. Financial performance
      • 10.7.24.3. Product benchmarking
      • 10.7.24.4. Strategic initiatives

Chapter 11 Key Takeaways

List of Tables

  • Table 1 Country share estimation
  • Table 2 List of market players
  • Table 3 North America Veterinary Renal Diseases market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 5 North America Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 6 North America Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 7 North America Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 8 North America Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 US Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 10 US Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 11 US Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 12 US Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 13 US Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 14 Canada Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 16 Canada Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 17 Canada Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 18 Canada Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 Europe Veterinary Renal Diseases market, by region, 2017- 2030 (USD Million)
  • Table 20 Europe Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 22 Europe Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 23 Europe Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 24 Europe Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 25 UK Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 26 UK Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 27 UK Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 28 UK Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 29 UK Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Germany Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 31 Germany Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 32 Germany Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 33 Germany Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Germany Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 35 Italy Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 36 Italy Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 37 Italy Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 38 Italy Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 39 Italy Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 40 France Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 41 France Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 42 France Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 43 France Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 44 France Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 Spain Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 46 Spain Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 47 Spain Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 48 Spain Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 49 Spain Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50 Denmark Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Denmark Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 52 Denmark Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million
  • Table 53 Denmark Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 54 Denmark Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 Sweden Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 56 Sweden Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 57 Sweden Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 58 Sweden Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 59 Sweden Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 60 Norway Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 61 Norway Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 62 Norway Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 63 North America Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 64 Norway Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Veterinary Renal Diseases market, by region, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 71 Japan Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 72 Japan Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 73 Japan Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 74 Japan Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 75 Japan Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 76 China Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 77 China Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 78 China Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 79 China Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 80 China Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 81 India Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 82 India Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 83 India Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 84 India Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 85 India Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 86 Australia Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 87 Australia Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 88 Australia Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 89 North America Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 90 Australia Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 91 Thailand Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 92 Thailand Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 93 Thailand Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 94 Thailand Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 95 Thailand Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 96 South Korea Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 97 South Korea Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 98 South Korea Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 99 South Korea Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 100 South Korea Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 101 Latin America Veterinary Renal Diseases market, by region, 2018 - 2030 (USD Million)
  • Table 102 Latin America Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 103 Latin America Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 104 Latin America Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 105 Latin America Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 106 Latin America Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 107 Brazil Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 108 Brazil Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 109 Brazil Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 110 Brazil Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 111 Brazil Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 112 Mexico Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 113 Mexico Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 114 Mexico Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 115 Mexico Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 116 Mexico Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 117 Argentina Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 118 Argentina Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 119 Argentina Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 120 Argentina Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 121 Argentina Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 122 MEA Veterinary Renal Diseases market, by region, 2018 - 2030 (USD Million)
  • Table 123 MEA Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 124 MEA Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 125 MEA Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 126 MEA Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 127 MEA Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 128 South Africa Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 129 South Africa Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 130 South Africa Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 131 South Africa Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 132 South Africa Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 137 Saudi Arabia Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 138 UAE Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 139 UAE Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 140 UAE Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 141 UAE Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 142 UAE Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 143 Kuwait Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 144 Kuwait Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 145 Kuwait Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 146 Kuwait Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 147 Kuwait Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 148 List of secondary sources
  • Table 149 List of emerging companies
  • Table 150 Canine, Feline, Equine & Bovine population (in millions)

List of Figures

  • Fig. 1 Veterinary Renal Diseases market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Data analysis models
  • Fig. 6 Market formulation and validation
  • Fig. 7 Data validating & publishing
  • Fig. 8 Commodity flow analysis
  • Fig. 9 Volume-price market analysis: veterinary renal diseases services market
  • Fig. 10 Ancillary market analysis
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Parent market outlook
  • Fig. 16 Ancillary market outlook
  • Fig. 17 Demographics of American pet owners, based on generation, %, 2022
  • Fig. 18 Demographics of American pet owners, based on generation, %, 2023
  • Fig. 19 veterinary renal diseases market dynamics
  • Fig. 20 veterinary renal diseases market: PORTER's analysis
  • Fig. 21 veterinary renal diseases market: PESTEL analysis
  • Fig. 22 veterinary renal diseases market by Type: Key takeaways
  • Fig. 23 veterinary renal diseases market by Type, market share, 2023 & 2030
  • Fig. 24 Diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 25 Treatment, 2018 - 2030 (USD Million)
  • Fig. 26 Drugs market, 2018 - 2030 (USD Million)
  • Fig. 27 veterinary renal diseases market by animal type: Key takeaways
  • Fig. 28 veterinary renal diseases market by animal type, market share, 2023 & 2030
  • Fig. 29 Canine market, 2018 - 2030 (USD Million)
  • Fig. 30 Feline market, 2018 - 2030 (USD Million)
  • Fig. 31 Bovine market, 2018 - 2030 (USD Million)
  • Fig. 32 Equine market, 2018 - 2030 (USD Million)
  • Fig. 33 Others market, 2018 - 2030 (USD Million)
  • Fig. 34 veterinary renal diseases market by route of administration: Key takeaways
  • Fig. 35 veterinary renal diseases market by route of administration, market share, 2023 & 2030
  • Fig. 36 Oral market, 2018 - 2030 (USD Million)
  • Fig. 37 Injectable market, 2018 - 2030 (USD Million)
  • Fig. 38 veterinary renal diseases market by indication: Key takeaways
  • Fig. 39 veterinary renal diseases market by Indication, market share, 2023 & 2030
  • Fig. 40 Renal Failure market, 2018 - 2030 (USD Million)
  • Fig. 41 Chronic Kidney Disease (CKD) market, 2018 - 2030 (USD Million)
  • Fig. 42 Renal Cystitis market, 2018 - 2030 (USD Million)
  • Fig. 43 Kidney Stones market, 2018 - 2030 (USD Million)
  • Fig. 44 Nephritis market, 2018 - 2030 (USD Million)
  • Fig. 45 Others market, 2018 - 2030 (USD Million)
  • Fig. 46 Veterinary Renal Diseases market by Distribution channel: Key takeaways
  • Fig. 47 Veterinary Renal Diseases market by distribution channel, market share, 2023 & 2030
  • Fig. 48 Veterinary hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 49 Pet Specialty Stores market, 2018 - 2030 (USD Million)
  • Fig. 50 E-commerce market, 2018 - 2030 (USD Million)
  • Fig. 51 Others market, 2018 - 2030 (USD Million)
  • Fig. 52 veterinary renal diseases market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 53 Regional market share analysis, 2023 & 2030
  • Fig. 54 Regional marketplace: key takeaways
  • Fig. 55 Regional marketplace: key takeaways
  • Fig. 56 North America: SWOT analysis
  • Fig. 57 North America veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 U.S. veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Canada veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Europe: SWOT analysis
  • Fig. 63 Europe veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Germany veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 UK veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 France veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Spain veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Italy veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Denmark veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Fih.72 Key country dynamics
  • Fig. 77 Norway veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Sweden veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Asia Pacific SWOT Analysis
  • Fig. 81 Asia Pacific veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Japan veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 China veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 India veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Australia veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Korea veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Thailand veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 94 Latin America SWOT analysis
  • Fig. 95 Latin America veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Brazil veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 98 Mexico veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 99 Argentina veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 MEA SWOT analysis
  • Fig. 101 MEA veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 South Africa veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 Saudi Arabia veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 UAE veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Kuwait veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 110 Market participant categorization
  • Fig. 111 Heat map analysis
  • Fig. 112 Key strategies deployed by market players